Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.

PubWeight™: 0.80^‹?›

🔗 View Article (PMID 1695763)

Published in Semin Hematol on July 01, 1990

Authors

Author Affiliations

1: Department of Medicine, University of Minnesota Medical Center, Minneapolis 54455.

Articles citing this ↘

Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood (2011) 1.55

Graft-versus-leukemia (GVL) against mouse blast-crisis chronic myelogenous leukemia (BC-CML) and chronic-phase chronic myelogenous leukemia (CP-CML): shared mechanisms of T cell killing, but programmed death ligands render CP-CML and not BC-CML GVL resistant. J Immunol (2011) 0.94

Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity. J Clin Invest (2017) 0.75